Motility and adhesiveness in human neutrophils. Redistribution of chemotactic factor-induced adhesion sites.
Human peripheral blood neutrophils obtained from healthy adults were examined in vitro. We assessed the effects of sequential stepwise increases in the concentration of the chemotactic dipeptide N-formyl-l-methionyl-l-phenylalanine (f-Met-Phe) on neutrophil attachment to serum-coated glass, detachment from serum-coated glass and the distribution on the cell surface of binding sites for albumin-coated latex beads. The initial exposure to f-Met-Phe resulted in increased adhesiveness and binding of latex beads in a random pattern over the cell surface. The second exposure to f-Met-Phe resulted in decreased adherence, detachment of neutrophils from serum-coated glass, and movement of binding sites for latex beads to the uropod. Enhanced adhesiveness and redistribution of binding sites were blocked by 0.1 mM N-alpha-p-tosyl-l-lysine chloromethyl ketone, a concentration that did not reduce the change in cellular shape caused by f-Met-Phe. Cytochalasin B (5 mug/ml) blocked the redistribution of binding sites as well as the change in shape. The third exposure to f-Met-Phe was given along with the latex beads. The stimulus was stopped after 2 min by fixing cells in suspension with glutaraldehyde. If the third exposure was at a concentration higher than the second, the beads were bound in the region of the lamellipodia in 70% of the cells. If lower, binding to the lamellipodia was found in a significantly smaller proportion of cells (13%). The results support the concept that neutrophils develop a polarized distribution of f-Met-Phe-induced adhesion sites in response to increasing concentrations of f-Met-Phe, and these sites flow from the region of the lamellipodia to the uropod.
D000328:Adult; D001665:Binding Sites; D002448:Cell Adhesion / Q000187:drug effects; D002630:Chemotactic Factors / Q000494:pharmacology*; D003571:Cytochalasin B / Q000494:pharmacology; D004151:Dipeptides / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D008855:Microscopy, Electron, Scanning; D009239:N-Formylmethionine / Q000031:analogs & derivatives / Q000494:pharmacology; D009504:Neutrophils / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D012709:Serum Albumin; D014107:Tosyllysine Chloromethyl Ketone / Q000494:pharmacology
D002630:Chemotactic Factors; D004151:Dipeptides; D012709:Serum Albumin; D014107:Tosyllysine Chloromethyl Ketone; C017330:N-formylmethionylphenylalanine; D003571:Cytochalasin B; D009239:N-Formylmethionine